1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dot1l reverses the abnormal self-renewal conferred on HSPCs through cohesin haploinsufficiency by diminishing expression of Hoxa7 and Hoxa9
    Meeting Abstract

    Fisher, J. B.; Stelloh, C.; Phillips, E. K.; Heimbruch, K.; Meyer, A. E.; Pulakanti, K.; McNulty, M.; Viny, A. D.; Levine, R. L.; Crispino, J. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • CD99 regulates normal and malignant stem cell function by restricting protein translation
    Meeting Abstract

    Chung, S. S.; Hu, W.; Guo, L.; Kannan, L.; Levine, R. L.; Park, C. Y.
    Blood (2017)

    Fulltext@MSK | Save
  • A knowledge-based approach for clinical annotation of oncogenic variants to support patient-tailored diagnosis in myeloid disease
    Meeting Abstract

    Bernard, E.; Yoshida, K.; Gundem, G.; Grinfeld, J.; Nangalia, J.; Leongamornlert, D.; Farnoud, N.; Medina, J.; Moarii, M.; Massie, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Multimodal microscopy for skin cancer diagnosis
    Journal Article

    Iftimia, N.; Rajadhyaksha, M.
    Journal of Molecular Imaging & Dynamics (2017)

    Fulltext@MSK | Save
  • In vivo intraoral reflectance confocal microscopy of an amalgam tattoo
    Journal Article

    Yélamos, O.; Cordova, M.; Peterson, G.; Pulitzer, M. P.; Singh, B.; Rajadhyaksha, M.; DeFazio, J. L.
    Dermatology Practical & Conceptual (2017)

    Fulltext@MSK | Save
  • [F18]PARPi PETas an in vivo biomarker of intratumoral parp inhibition in small cell lung cancer
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Radiation Oncology (2017)

    Fulltext@MSK | Save
  • Classification and risk assessment in AML: Integrating cytogenetics and molecular profiling
    Journal Article

    Moarii, M.; Papaemmanuil, E.
    Hematology-American Society of Hematology Education Program (2017)

    Fulltext@MSK | Save
  • TET2 in normal and malignant hematopoiesis
    Journal Article

    Bowman, R. L.; Levine, R. L.
    Cold Spring Harbor Perspectives in Medicine (2017)

    Fulltext@MSK | Save
  • Cylindrical graphene nanomaterials for disease assessment and drug development
    Meeting Abstract

    Heller, D.; Budhathoki-Uprety, J.; Frederiksen, R.; Galassi, T.; Harvey, J.; Horoszko, C.; Jena, P.; Langenbacher, R.; Roxbury, D.; Shah, J.; more...
    Abstracts of Papers of the American Chemical Society (2017)

    Fulltext@MSK | Save